Laurie Womack
Family Medicine · Perryville, MONPI 1942392618
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 270 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 51.4% of the total. Reporting peaked in 2022 at $1,368 and has fallen 65.8% since, to $468 in 2025. Among family medicine clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 270 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lilly USA, LLC$341
- Novartis$317
- Novo Nordisk$299
- Amgen$217
- Boehringer Ingelheim$165
- plus $1K from 22 others
What the payments were for
- Food & beverage$5,221100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 121 | $2,685 |
| Lilly USA, LLC | 20 | $341 |
| Novartis | 14 | $317 |
| Novo Nordisk | 16 | $299 |
| Amgen | 14 | $217 |
| Boehringer Ingelheim | 11 | $165 |
| Bayer | 6 | $119 |
| GSK | 8 | $118 |
| Johnson & Johnson | 7 | $110 |
| Merck | 6 | $105 |
| AstraZeneca | 7 | $100 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $89 |
| Astellas Pharma US Inc | 5 | $78 |
| Amarin Pharma, Inc. | 4 | $70 |
| Sumitomo Pharma America, Inc. | 5 | $67 |
| Medtronic | 2 | $40 |
| Pfizer | 3 | $39 |
| Abbott | 2 | $36 |
| Dexcom, Inc. | 2 | $33 |
| Abiomed | 1 | $33 |
| Eisai Inc. | 2 | $32 |
| Sunovion Pharmaceuticals Inc. | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 2 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Mylan Specialty L.p. | 1 | $11 |
How this compares
$5,221 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 64 | $86,802 |
| OzempicSemaglutide | 58 | $75,528 |
| EliquisApixaban | 127 | $70,430 |
| TrulicityDulaglutide | 51 | $66,934 |
| FarxigaDapagliflozin Propanediol | 71 | $65,699 |
| MounjaroTirzepatide | 52 | $59,692 |
| VascepaIcosapent Ethyl | 38 | $26,138 |
| XareltoRivaroxaban | 38 | $24,244 |
| RybelsusSemaglutide | 13 | $21,267 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $19,312 |
| SynjardyEmpagliflozin/Metformin Hcl | 11 | $17,234 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 31 | $16,150 |
| GemtesaVibegron | 21 | $9,760 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 29 | $7,850 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 40 | $7,205 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $341 | $126,626103 claims |
| Boehringer IngelheimJardiance, Synjardy, Synjardy Xr | $165 | $110,52487 claims |
| Novo NordiskOzempic, Rybelsus | $299 | $96,79571 claims |
| PfizerEliquis, Abrysvo | $39 | $78,280156 claims |
| AstraZenecaFarxiga | $100 | $65,69971 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $118 | $35,46253 claims |
| Johnson & JohnsonXarelto | $110 | $24,24438 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $67 | $9,76021 claims |
| AbbVieSynthroid | $2,685 | $2,23120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Perryville
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.